Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-02-27

Clinical Trial Update: Nitrous Oxide For Endoscopic Ablation of Refractory Barrett's Esophagus (NO FEAR-BE) [NA]

View source ↗

Summary

This clinical trial update reports on the NO FEAR-BE study evaluating nitrous oxide for endoscopic ablation in Barrett's esophagus with intestinal metaplasia an…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Nitrous oxide (nitrous oxide)

Snippet

Sponsor: University of North Carolina, Chapel Hill | Conditions: Barrett Esophagus, Intestinal Metaplasia | NA | Status: ACTIVE_NOT_RECRUITING